CLINICAL TRIAL SOLUTIONS

Full Service: Phase II-IV CRO

Our Phase II-IV CRO services give sponsors the support they need to meet study goals on time.

How can we support you?

Explore our Phase II-IV CRO Services

PharPoint works diligently to help clients plan, manage, and analyze effective clinical trials, and has experience supporting Phase II-IV trials.

Site Feasibility

Our analysis and insight can help sponsors effortlessly identify effective sites that can meet study goals.

Clinical Operations

Our team works to ensure study excellence and transparent collaboration between CRO, site, and Sponsor.

Clinical data management

Work with a clinical data management team that prioritizes your data from day one.

Biostatistics & Statistical Programming

Our consultative approach to biostatistics services includes a level of responsiveness, support, and proactiveness that is unmatched within the industry.


THE PHARPOINT DIFFERENCE

Helping sponsors meet their study goals

A COLLABORATIVE TEAM

For Study Success

PharPoint aligns sponsors with teammates that have the right knowledge and experience to overcome potential study challenges. These teammates work collaboratively across functions to support studies from all angles, always working with your end goals in mind.

IDENTIFY THE RIGHT SITES

with PharPoint’s Strategic Site Feasibility

Finding the right sites to support your trial is a vital step in ensuring your study will enroll on time. We have experience working with locations across the United States as well as supporting global studies via our CRO partners in APAC.

We prioritize identifying and selecting the best-possible sites for your unique study details and requirements. This process evaluates factors such as availability, competing studies, patient access, and unique capabilities and experience – ultimately matching clients with partners that will help them meet study goals.

GET RESULTS FASTER

with PharPoint’s Industry-Best Biometrics Timelines

At every step, PharPoint’s standard biometrics CRO timelines are industry-best. Throughout your study, clean data are soft locked, reducing the number of subjects needing to be locked following Last Participant, Last Visit (LPLV) and decreasing the timeline to database lock to only 5 days after final Source Document Verification (SDV).